Cove Capital Buys New Orleans Dialysis Facility for DST Offering
Cove Capital Investments LLC, a sponsor of debt-free Delaware statutory trust offerings, has purchased a dialysis facility located in LaPlace, Louisiana.
Cove Capital Investments LLC, a sponsor of debt-free Delaware statutory trust offerings, has purchased a dialysis facility in LaPlace, Louisiana.
The property, located at 704 Belle Terre Blvd, is net leased to Fresenius Medical Care (NYSE: FMS), an outpatient kidney dialysis services provider. According to a filing with the Securities and Exchange Commission, Cove Capital launched its Regulation D Rule 506(c) offering, Cove LaPlace Dialysis 26 DST, in January 2021 and seeks to raise nearly $5.6 million in investor equity.
Cove Capital Investments creates 1031 exchange DST investments for accredited investors. The firm’s principals have sponsored and co-sponsored the syndication of more than 1.3 million square feet of DST properties in the multifamily, net lease, industrial and office sectors, according to the company’s website.
